Healthcare Services

Real World Evidence Solutions Market Size Outlook and Demand Growth Across 2026–2030

April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Real World Evidence Solutions Market Evolve From 2026 To 2030?

The real world evidence solutions market size has seen swift expansion in recent years. It is anticipated to expand from $2.33 billion in 2025 to $2.7 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.9%. This past growth can be ascribed to several factors, including the increasing accessibility of real-world healthcare data, a growing need for post-approval evidence, a heightened emphasis on drug safety monitoring, the wider adoption of electronic health records, and the initial regulatory acceptance of RWE.

The market for real world evidence solutions is projected to experience substantial expansion in the coming years. Its valuation is set to reach $4.81 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.6%. This projected growth is primarily fueled by factors such as data-driven regulatory decision-making, the increasing application of real-world evidence (RWE) in reimbursement determinations, the broadening scope of precision medicine initiatives, the enhanced integration of real-time healthcare data, and the rising uptake of AI-powered evidence platforms. Key developments anticipated during this period encompass a greater utilization of advanced analytics in RWE research, the expanding integration of electronic health records (EHR) and claims data, the heightened adoption of AI-driven evidence generation, the wider incorporation of RWE into regulatory submissions, and an intensified focus on monitoring post-market safety.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6930&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Real World Evidence Solutions Market?

The expansion of the elderly demographic is anticipated to stimulate the growth of the real-world evidence solutions market. This demographic includes individuals aged 65 and above, who face an elevated susceptibility to falls due to factors like postural hypotension, along with balance or gait difficulties. Furthermore, advancing age heightens the likelihood of developing chronic conditions such as strokes, cardiovascular diseases, type 2 diabetes, arthritis, and cancer. For example, data released in January 2024 by the US-based nonprofit organization, the Population Reference Bureau, indicated that the number of Americans aged 65 and older is projected to climb from 58 million in 2022 to 82 million by 2050, marking a 47% rise. Concurrently, their proportion of the overall population is forecasted to increase from 17% to 23%. Consequently, the increasing geriatric population is fueling the expansion of the real-world evidence solutions market.

Which Segment Areas Are Covered In The Real World Evidence Solutions Market Analysis?

The real world evidence solutions market covered in this report is segmented –

1) By Component: Services, Data Sets, Clinical Setting Data, Claims Data, Pharmacy Data, Patient Powered Data

2) By Therapeutic Area: Oncology, Cardiovascular, Neurology, Immunology, Other Therapeutic Areas

3) By Application: Drug Development And Approvals, Medical Device Development And Approvals, Reimbursement/Coverage And Regulatory Decision Making, Post Market Safety And Adverse Events Monitoring

4) By End-Users: Pharmaceutical And Medical Devices Companies, Healthcare Providers, Healthcare Payers, Other End-Users

Subsegments:

1) By Services: Consulting Services, Data Management Services, Regulatory Services, Analytics Services

2) By Data Sets: Electronic Health Records (EHR), Patient Registries, Clinical Trials Data, Observational Study Data

3) By Clinical Setting Data: Hospital Data, Outpatient Data, Specialty Care Data, Claims Data

4) By Insurance Claims Data: Medicare/Medicaid Data, Commercial Claims Data, Pharmacy Data

5) By Prescription Data: Pharmacy Claims Data, Drug Utilization Data

6) By Patient Powered Data: Patient Surveys, Patient-Reported Outcomes (PRO), Wearable Device Data

What Trends Are Advancing Progress In The Real World Evidence Solutions Market?

Leading companies in the real-world evidence solutions market are developing innovative offerings, such as a new real-world evidence (RWE) solutions service, intended to optimize evidence-based medicine. These RWE solutions services are created to generate and analyze clinical evidence concerning the usage, potential benefits, and risks of medical products, utilizing real-world data (RWD) that originates from routine healthcare delivery. For example, in October 2023, Maxis Clinical Sciences, a US-based clinical research consultancy assisting small to medium-sized pharmaceutical and life sciences companies globally, introduced its new Real-World Evidence (RWE) Solutions service. Maxis Clinical Sciences’ RWE Solutions was established to combine multiple RWD sources, including patient-reported outcomes and data from wearable devices, specifically designed to enhance patient participation and data quality.

Which Global Companies Are Actively Competing In The Real World Evidence Solutions Market?

Major companies operating in the real world evidence solutions market are Anthem Inc., Cegedim Health Data, Clarivate PLC, Cognizant Technology Solutions Corporation, Flatiron Health Inc., International Business Machines Corporation, ICON plc, IQVIA Holdings Inc., Medpace Holdings Inc., Optum Inc., Oracle Corporation, PAREXEL International Corporation, PPD Inc., SAS Institute Inc., Syneos Health, Symphony Innovation LLC, UnitedHealth Group Incorporated, Deloitte Touche Tohmatsu Limited, Informa PLC, Palantir Technologies, UDG Healthcare PLC, Elevance Health Inc., Covance Consulting Ltd., Clinipace Worldwide, Evidera Inc., Pharmerit International, Analysis Group Inc., HealthCore Inc., Inovalon Holdings Inc., KMK Consulting Inc.

Read the full real world evidence solutions market report here:

https://www.thebusinessresearchcompany.com/report/real-world-evidence-solutions-global-market-report

What Are The Leading Geographic Regions In The Real World Evidence Solutions Market?

North America was the largest region in the real world evidence solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the real world evidence solutions market share during the forecast period. The regions covered in the real world evidence solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Real World Evidence Solutions Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6930&type=smp

Browse Through More Reports Similar to the Global Real World Evidence Solutions Market 2026, By The Business Research Company

Digital Health Monitoring Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/digital-health-monitoring-devices-global-market-report

Patient Monitoring Devices Market

https://www.thebusinessresearchcompany.com/report/patient-monitoring-devices-market

Remote Health Monitoring Global Market Report

https://www.thebusinessresearchcompany.com/report/remote-health-monitoring-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795